|
Event Registration for Industry Professionals | Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Lung Cancer — January 25, 2018, San Francisco, CAThis activity is intended for medical, radiation and thoracic oncologists and other healthcare providers involved in the treatment of lung cancer. |